Gain-of-function mutation in Gnao1: A murine model of epileptiform encephalopathy (EIEE17)?

Mammalian Genome

Volumn 25, Issue 5-6, 2014, Pages 202-210

  Kehrl, Jason M ^a   Sahaya, Kinshuk ^b   Dalton, Hans M ^a   Charbeneau, Raelene A ^a   Kohut, Kevin T ^a   Gilbert, Kristen ^a   Pelz, Madeline C ^a   Parent, Jack ^b,c   Neubig, Richard R ^d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Veterans Administration Ann Arbor Healthcare Systems   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN G (O) SUBUNIT ALPHA; RGS PROTEIN; UNCLASSIFIED DRUG; GNAO1 PROTEIN, MOUSE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DISEASE; CHROMOSOME 17; CONTROLLED STUDY; EARLY INFANTILE EPILEPTIFORM ENCEPHALOPATHY 17; EEG ABNORMALITY; EPILEPTIC DISCHARGE; FEMALE; GAIN OF FUNCTION MUTATION; KINDLING; MALE; MOUSE; NONHUMAN; SEIZURE; SUDDEN DEATH; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; EPILEPSY; GENE TARGETING; GENETICS; HUMAN; METABOLISM; MORTALITY; MUTATION; PATHOLOGY;

MURINAE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; EPILEPSY; FEMALE; GENE KNOCK-IN TECHNIQUES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; MALE; MICE; MICE, INBRED C57BL; MUTATION;

EID: 84902135006     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-014-9509-z     Document Type: Article

References (33)

1. Bergren SK, Chen S, Galecki A, Kearney JA (2005) Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a. Mamm Genome 16:683-690
2. Bergren SK, Rutter ED, Kearney JA (2009) Fine mapping of an epilepsy modifier gene on mouse Chromosome 19. Mamm Genome 20:359-366
3. Bialer M, White HS (2010) Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov 9:68-82
4. Birnbaumer L (2007) Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers. Biochim Biophys Acta 1768:772-793
5. Chen H, Lambert NA (2000) Endogenous regulators of G protein signaling proteins regulate presynaptic inhibition at rat hippocampal synapses. Proc Natl Acad Sci USA 97:12810-12815
6. Chen Y, Liu Y, Cottingham C, McMahon L, Jiao K, Greengard P, Wang Q (2012) Neurabin scaffolding of adenosine receptor and RGS4 regulates anti-seizure effect of endogenous adenosine. J Neurosci 32:2683-2695
7. Clark MJ, Harrison C, Zhong H, Neubig RR, Traynor JR (2003) Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways. J Biol Chem 278:9418-9425
8. Dhir A (2012) Pentylenetetrazol (PTZ) kindling model of epilepsy. Current protocols in neuroscience/editorial board, JN Crawley et al. Chapt. 9, Unit 9, 37
9. Engel J Jr (1996) Surgery for seizures. N Engl J Med 334:647-652
10. Ferraro TN, Golden GT, Smith GG, St Jean P, Schork NJ, Mulholland N, Ballas C, Schill J, Buono RJ, Berrettini WH (1999) Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J Neurosci 19:6733-6739
11. Fu Y, Huang X, Zhong H, Mortensen RM, D'Alecy LG, Neubig RR (2006) Endogenous RGS proteins and Galpha subtypes differentially control muscarinic and adenosine-mediated chronotropic effects. Circ Res 98:659-666
12. Golarai G, Cavazos JE, Sutula TP (1992) Activation of the dentate gyrus by pentylenetetrazol evoked seizures induces mossy fiber synaptic reorganization. Brain Res 593:257-264
13. Goldenstein BL, Nelson BW, Xu K, Luger EJ, Pribula JA, Wald JM, O'Shea LA, Weinshenker D, Charbeneau RA, Huang X et al (2009) Regulator of G protein signaling protein suppression of Galphao protein-mediated alpha2A adrenergic receptor inhibition of mouse hippocampal CA3 epileptiform activity. Mol Pharmacol 75:1222-1230
14. Grecksch G, Becker A, Schroeder H, Kraus J, Loh H, Hollt V (2004) Accelerated kindling development in mu-opioid receptor deficient mice. Naunyn Schmiedebergs Arch Pharmacol 369:287-293
15. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007) How common are the "common" neurologic disorders? Neurology 68:326-337
16. Ikeda SR, Jeong SW (2004) Use of RGS-insensitive Galpha subunits to study endogenous RGS protein action on G-protein modulation of N-type calcium channels in sympathetic neurons. Methods Enzymol 389:170-189
17. Khosravani H, Zamponi GW (2006) Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev 86:941-966
18. Lamberts JT, Smith CE, Li MH, Ingram SL, Neubig RR, Traynor JR (2013) Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Galphao protein. J Neurosci 33:4369-4377
19. Lee CH, Javed D, Althaus AL, Parent JM, Umemori H (2012) Neurogenesis is enhanced and mossy fiber sprouting arises in FGF7-deficient mice during development. Mol Cell Neurosci 51:61-67
20. Li T, Steinbeck JA, Lusardi T, Koch P, Lan JQ, Wilz A, Segschneider M, Simon RP, Brustle O, Boison D (2007) Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain 130:1276-1288
21. Loscher W (2011) Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20:359-368
22. Machin D, Cheung YB, Parmar MKB, Parmar MKB (2006) Survival analysis: a practical approach, 2nd edn. Chichester, Hoboken
23. Masino SA, Li T, Theofilas P, Sandau US, Ruskin DN, Fredholm BB, Geiger JD, Aronica E, Boison D (2011) A ketogenic diet suppresses seizures in mice through adenosine A(1) receptors. J Clin Investig 121:2679-2683
24. Meisler MH, Kearney JA (2005) Sodium channel mutations in epilepsy and other neurological disorders. J Clin Investig 115:2010-2017
25. Michelucci R, Pasini E, Riguzzi P, Volpi L, Dazzo E, Nobile C (2012) Genetics of epilepsy and relevance to current practice. Curr Neurol Neurosci Rep 12:445-455
26. Morimoto K, Fahnestock M, Racine RJ (2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73:1-60
27. Nakamura K, Kodera H, Akita T, Shiina M, Kato M, Hoshino H, Terashima H, Osaka H, Nakamura S, Tohyama J et al (2013) De Novo mutations in GNAO1, encoding a Galphao subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet 93:496-505
28. Ormandy GC, Jope RS (1991) Pertussis toxin potentiates seizures induced by pilocarpine, kainic acid and N-methyl-d-aspartate. Brain Res 553:51-57
29. Peterson SL, Albertson TE (1998) Neuropharmacology methods in epilepsy research. CRC, Boca Raton
30. Valenzuela D, Han X, Mende U, Fankhauser C, Mashimo H, Huang P, Pfeffer J, Neer EJ, Fishman MC (1997) G alpha(o) is necessary for muscarinic regulation of Ca2+ channels in mouse heart. Proc Natl Acad Sci USA 94:1727-1732
31. Wilczynski GM, Konopacki FA, Wilczek E, Lasiecka Z, Gorlewicz A, Michaluk P, Wawrzyniak M, Malinowska M, Okulski P, Kolodziej LR et al (2008) Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol 180:1021-1035
32. Williams SM, Haines JL (2011) Correcting away the hidden heritability. Ann Hum Genet 75:348-350
33. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ, McKnight GS, Scheuer T, Catterall WA (2006) Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9:1142-1149